Cancer Research UK announces clinical trial for a most common type of lung cancer Cancer Research UK has announced that the first patient has been …

Clinical stage outfit, Destiny Pharma, provides a positive summary of the year ahead Clinical stage outfit, Destiny Pharma, has announced an update of its late-stage …

If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at Pharma innovation specialists, Poolbeg Pharma–a …

Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation to include the advancement of new …

AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from the trial immunogenicity and safety …

Despite diagnosis and treatment options improving for the rare kidney condition, further action is urgently required. Kidney Research UK and the Stoneygate Trust have announced …

The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time …

There is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in the UK currently diagnosed with the disease. …

The UK government has warned that more than 96% of pregnant people admitted to hospital with COVID-19 symptoms were unvaccinated, in analysis between the months …

The chronic, inflammatory disease affects an estimated 24 in every 10,000 people. The National Institute for Health and Care Excellence (NICE) has issued a final …